Afonso, Carlos (Univ Rouen 201606) |
Laboratory Manager (industry) |
University of Rouen (Université de Rouen) |
Rouen |
Alem, Liza (AZMed 202402 Head of Marketing + Communication) |
Sales Manager / Marketing Manager |
AZmed S.A.S. |
Laval (FR) |
Avenard, Gilles (Acticor Biotech 201612 CEO) |
Chief Executive Officer (CEO) |
Acticor Biotech (Group) |
Paris |
Bachelot-Fontaine, Laetitia (Valneva 201404 Investor Relations + Communications Manager) |
Public Relations Manager / Investor Relations Manager |
Valneva (Group) |
Nantes |
Balusson, Hervé (Olmix 201508 CEO + Founder + Board Director of Biotech France) |
Chief Executive Officer (CEO) |
Olmix (Group) |
Bretagne (Britanny) (region) |
Bauer, Grégory (Atlanpole 201411 International Marketing Manager at Atlanpole Biotherapies) |
Cluster Manager |
Atlanpole (FR) |
Nantes |
Béchard, David (Cytune Pharma 201502 President + Founder) |
Chief Executive Officer (CEO) |
Cytune Pharma S.A.S. |
Nantes |
Bellocq, Chloé (In-Cell-Art 200709– CEO) |
Chief Executive Officer (CEO) |
In-Cell-Art S.A.S. |
Nantes |
Bencteux, Philippe (Robocath 2009– Chairman + Founder) |
Board member |
Robocath S.A.S. |
Rouen |
Blavier, André (Interactive Biosoftware 201211 CEO + Founder) |
Chief Executive Officer (CEO) |
Sophia Genetics (Group) |
Rouen |
Bühler, Peter (Valneva 202107– CFO ANNOUNCED before Quotient + Zaluvida + Stallergenes Greer + Lilly + Merck Serono) |
Chief Financial Officer (CFO) |
Valneva (Group) |
Nantes |
Debus, Nils P. (iOmx Therapeutics 202309– CBO before OSE Immunotherapeutics + Boehringer + Merz + Schering) |
Chief Business Officer (CBO) |
iOmx Therapeutics AG |
Martinsried |
Dennery, Xavier (Eurofins 200704– CEO Environment testing business has been 2y before w Eurofins) |
Chief Executive Officer (CEO) |
Eurofins (Group) |
Nantes |
Drumm, Joshua (Valneva 202108 VP Global Investor Relations before AC Immune) |
Public Relations Manager / Investor Relations Manager |
Valneva (Group) |
Nantes |
Duvaux, Odile (Xenothera 202106 President + Founder) |
President/Director/Head Business Group/Unit/Division |
Xenothera (FR) |
Nantes |
Faye, Loïc (Angany Genetics 201304 CEO) |
Chief Executive Officer (CEO) |
Angany Genetics (FR) |
Rouen |
Festoc, Gabriel (Polyplus-transfection 201609 CEO before CEO + Founder of GeneSystems) |
Chief Executive Officer (CEO) |
Sartorius (Group) |
Illkirch |
Goffart, Lucien (Robocath 202004 CEO) |
Chief Executive Officer (CEO) |
Robocath S.A.S. |
Rouen |
Grimaud, Franck (Vivalis 200702 CEO) |
Chief Executive Officer (CEO) |
Valneva (Group) |
Nantes |
Guillot, Thomas (OSE Immunotherapeutics 202210 Invesor Relations) |
Public Relations Manager / Investor Relations Manager |
OSE Immunotherapeutics (Group) |
Nantes |
Hess, Philipp (Laboratoire Phycotoxines 201309) |
Researcher (university / research institute) |
Laboratoire Phycotoxines, Infremer |
Nantes |
Hiance, Maryvonne (France Biotech 201902 CHairman + Effimune 201310 President) |
Cluster Manager |
France Biotech |
Paris |
Hoffmann, Caroline (Oxygen 202206) |
Public Relations Manager / Investor Relations Manager |
Oxygen S.A.S. (RP, Agence Conseil en Communication Media) |
Nanterre |
Jacotot, Frederic (Valneva 201704– General Counsel + Board Member joined 2013 before Abbott) |
General Counsel / Chief Legal Officer (CLO) |
Valneva (Group) |
Nantes |
Kandera, Reinhard (Hookipa Biotech 201704– CFO before Valneva CFO + Intercell CFO + Deutsche Bank AG) |
Chief Financial Officer (CFO) |
Hookipa (Group) |
Wien (Vienna) |
Kitten, Olivier (Affilogic 201508 CEO) |
Chief Executive Officer (CEO) |
Affilogic S.A.S. |
Nantes |
Labal, Rodolphe (Eurofins 201703 Managing Director of Eurofins Food Testing France) |
Managing Director |
Eurofins (Group) |
Nantes |
Lawrence, David (Valneva 201708– CFO before Acambis + Chiron Vaccines + GSK) |
Chief Financial Officer (CFO) |
Valneva (Group) |
Nantes |
Le Mellay, Morgane (Robocath 20204 Communications+ Marketing Manager) |
Public Relations Manager / Investor Relations Manager |
Robocath S.A.S. |
Rouen |
Leroy, Luc (Eurofins 200710– CEO Pharma Services before SGS Managing Director UK) |
Chief Executive Officer (CEO) |
Eurofins (Group) |
Nantes |
Martin, Gilles G. (Eurofins 200701 CEO + founder) |
Chief Executive Officer (CEO) |
Eurofins (Group) |
Nantes |
Mehtali, Majid (Valneva –201308 CSO before Vivalis since 2003 + Deltagen Europe + Crucell DIED 8/13) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Valneva (Group) |
Nantes |
Menoret, Emmanuelle (Myelomax 201212 CEO) |
Chief Executive Officer (CEO) |
Myelomax S.A.S. |
Nantes |
Meyer, Olivier (Carlina Technologies 201411 CEO) |
Chief Executive Officer (CEO) |
Carlina Technologies (FR) |
Angers |
Miniou, Pierre (Vivalis 200904 Director BusDev) |
Business Development Manager / Strategy Manager |
Valneva (Group) |
Nantes |
Nicolas, Leila (Go Capital (FR) 201801 Investment Director) |
Investment Manager |
GO Capital (FR) |
Rennes |
Parisot, Jean-Yves (Symrise 202403– CEO joined 2014 before Diana Group + Air Liquide + Danisco) |
Chief Executive Officer (CEO) |
Symrise (Group) |
Holzminden |
Patel, Dipal (Valneva 202211– Chief Commercial Officer before GSK) |
Chief Commercial Officer (CCO) |
Valneva (Group) |
Nantes |
Poirier, Nicolas (OSE Immunotherapeutics 202210– CEO + CSO before CSO before Effimune + Tcl Pharma) |
Chief Executive Officer (CEO) |
OSE Immunotherapeutics (Group) |
Nantes |
Prel, Nadége (Affilogic 201508 Director Marketing + Business Development) |
Sales Manager / Marketing Manager |
Affilogic S.A.S. |
Nantes |
Reghal, Amokrane (Atlangram 201412 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Atlangram (FR) |
Nantes |
Rousselot, Morgane (SeaBeLife 202203 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
SeaBeLife S.A.S. |
Bretagne (Britanny) (region) |
Sharma, Ashwani (Eurosafe Sarl 201807 General Manager) |
General Manager (management) |
Eurosafe S.àr.l. |
Saint-Grégoire, Ille-et-Vilaine |
Sharp, Dan (Valneva 202104 Government + Public Affairs Manager) |
Public Relations Manager / Investor Relations Manager |
Valneva (Group) |
Nantes |
Spurling, Darryl (GeneSystems 200809 CEO) |
Chief Executive Officer (CEO) |
Danaher (Group) |
Bruz |
Vanhove, Bernard (OSE Immunotherapeutics 201707 COO) |
Chief Operating Officer (COO) |
OSE Immunotherapeutics (Group) |
Nantes |
Vidal, Julien (AZMed 202402 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
AZmed S.A.S. |
Laval (FR) |
Weber, Matthias-Wilbur (Eurofins 200701–201412 CFO died 12/14) |
Chief Financial Officer (CFO) |
Eurofins (Group) |
Nantes |